CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Loss of ALCAM/CD166 partially protects against diabetic nephropathy
DOI 10.1055/s-0035-1549526
Bibliografische Angaben
Nachweis in CareLit
Autor:innenR von Bauer, A Sulaj, S Kopf, E Gröne, HJ Gröne, S Hoffmann, E Schleicher, HU Häring, V Schwenger, S Herzig, PP Nawroth, T Fleming
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction/Background: Activated leukocyte cell adhesion molecule (ALCAM/CD166) has been shown to function as a pattern recognition receptor, analogue to the receptor of advanced glycation endproducts. In this study role of ALCAM in diabetic nephropathy was investigated in patients with type 2 diabetes, and further investigated in vitro and in vivo using homozygous knock-out mice for ALCAM (ALCAM-/-). Materials an…
Zitieren
Zitierempfehlung
R von Bauer, A Sulaj, S Kopf, E Gröne, HJ Gröne, S Hoffmann, E Schleicher, HU Häring, V Schwenger, S Herzig, PP Nawroth, T Fleming (2015) Loss of ALCAM/CD166 partially protects against diabetic nephropathy. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0035-1549526
Mit CareLit weiterarbeiten